PMC:7247521 / 448-2384 12 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T16 | 96-104 | SP_7 | denotes | COVID-19 |
| T17 | 135-144 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T18 | 440-445 | CHEBI:18059;CHEBI:18059;GO:0006629 | denotes | lipid |
| T19 | 446-463 | GO:0006629 | denotes | metabolic process |
| T20 | 465-484 | GO:0042592 | denotes | homeostatic process |
| T21 | 508-515 | CHEBI:35341;CHEBI:35341;GO:0006694 | denotes | steroid |
| T22 | 516-528 | GO:0006694 | denotes | biosynthesis |
| T23 | 667-676 | UBERON:0002048 | denotes | pulmonary |
| T24 | 693-698 | SO:0000276 | denotes | miRNA |
| T25 | 717-721 | PR:000005265 | denotes | CDK7 |
| T26 | 808-812 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T27 | 816-826 | GO:0010467 | denotes | expression |
| T28 | 1001-1010 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T29 | 1065-1069 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T30 | 1094-1110 | UBERON:0001555 | denotes | gastrointestinal |
| T31 | 1219-1221 | CHEBI:15379;CHEBI:15379 | denotes | O2 |
| T32 | 1329-1338 | SP_7 | denotes | 2019-nCov |
| T33 | 1386-1390 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T34 | 1407-1415 | SP_7 | denotes | COVID-19 |
| T35 | 1472-1480 | SP_7 | denotes | COVID-19 |
| T36 | 1522-1531 | GO:0010467 | denotes | expressed |
| T37 | 1532-1536 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T38 | 1578-1587 | NCBITaxon:2 | denotes | bacterial |
| T39 | 1592-1597 | NCBITaxon:10239 | denotes | viral |
| T40 | 1609-1622 | UBERON:0002405 | denotes | immune system |
| T41 | 1734-1742 | SP_7 | denotes | COVID-19 |
| T42 | 1746-1756 | GO:0065007 | denotes | regulating |
| T43 | 1857-1867 | GO:0065007 | denotes | regulation |
| T44 | 1876-1881 | NCBITaxon:10239 | denotes | viral |
| T11 | 1876-1881 | NCBITaxon:10239 | denotes | viral |
| T12 | 1887-1900 | CHEBI:67079;CHEBI:67079 | denotes | -inflammatory |
| T45 | 1914-1923 | GO:0008152 | denotes | metabolic |
| T13 | 1914-1923 | GO:0008152 | denotes | metabolic |